| CNVVF Stock | | | USD 2.95 0.10 3.51% |
President
Supratim Bose is Executive Vice President and President APAC of ConvaTec Group Plc since 2018.
| Age | 71 |
| Tenure | 6 years |
| Phone | 44 11 8952 8100 |
| Web | https://www.convatecgroup.com |
ConvaTec Group Management Efficiency
The company has return on total asset
(ROA) of
0.0354 % which means that it generated a profit of $0.0354 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0486 %, meaning that it generated $0.0486 on every $100 dollars invested by stockholders. ConvaTec Group's management efficiency ratios could be used to measure how well ConvaTec Group manages its routine affairs as well as how well it operates its assets and liabilities.
ConvaTec Group Plc has accumulated 1.2
B in total debt with debt to equity ratio
(D/E) of 0.85, which is about average as compared to similar companies. ConvaTec Group Plc has a current ratio of 1.91, which is within standard range for the sector. Debt can assist ConvaTec Group until it has trouble settling it off, either with new capital or with free cash flow. So, ConvaTec Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like ConvaTec Group Plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ConvaTec to invest in growth at high rates of return. When we think about ConvaTec Group's use of debt, we should always consider it together with cash and equity.
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. The company was founded in 1978 and is headquartered in Reading, the United Kingdom. Convatec Group operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 10142 people. ConvaTec Group Plc [CNVVF] is a
Pink Sheet which is traded between brokers over the counter.
Management Performance
ConvaTec Group Plc Leadership Team
Elected by the shareholders, the ConvaTec Group's board of directors comprises two types of representatives: ConvaTec Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ConvaTec. The board's role is to monitor ConvaTec Group's management team and ensure that shareholders' interests are well served. ConvaTec Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ConvaTec Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Frank Schulkes, CFO - Designate | |
| Karim Bitar, CEO Director | |
| Supratim Bose, Executive Vice President and President APAC | |
| Natalia Kozmina, Ex Officer | |
| Mark Reynolds, Director Relations | |
| Jonathan Mason, Group Director | |
| Donal Balfe, Executive Vice President - Global Operations | |
| Divakar Ramakrishnan, Ex Officer | |
| Kate Postans, VP Communications | |
| MSc Biotechnology, Pres Care | |
| Christian Hoengaard, VP USA | |
ConvaTec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is ConvaTec Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in ConvaTec Pink Sheet
ConvaTec Group financial ratios help investors to determine whether ConvaTec Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ConvaTec with respect to the benefits of owning ConvaTec Group security.